Clinical Case Reports, Research & Trials ISSN : 2581-6756
Kevin G Culligan

Pathophysiology, Physiology & Pharmacology

Firecrest Clinical


Journal Short Name - CCRRT


Ph.D. Pharmacology University College Dublin 2001 Postdoctoral Research Fellow - Royal College of Surgeons in Ireland (2001-2005) Lecturer/Senior lecturer in Pharmacology & Biology - Royal College of Surgeons in Ireland - Bahrain (2005-2013) Adjunct lecturer in Pathophysiology, Physiology & Pharmacology - Galway-Mayo Institute of Technology (2013-2014) Firecrest Clinical, ICON Plc.(2014 - Present)

Reasearch Interest

My research group, based in RCSI Bahrain studies polymorphic alterations to genes associated with conveying resistance to or protecting the body from the effects of insulin. These genes encode for cytokines termed adipokines, that are predominantly released from adipose tissue. Most of these adipokines are released in increasing amounts with increasing visceral adiposity, with the association of type 2 Diabetes mellitus and obesity termed Diabesity. We also hold grants to discover marine-based compounds to act as novel chemotherapeutic agents and antibiotics.

Signup to recive email updatesx